Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Arrayit Corp. (OTC: ARYC).

Full DD Report for ARYC

You must become a subscriber to view this report.


Recent News from (OTC: ARYC)

Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers
Sunnyvale, Aug. 27, 2018 (GLOBE NEWSWIRE) -- August 27, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces allergy testing partnerships with multiple providers of allergen immunotherapy products including sub-cutan...
Source: GlobeNewswire
Date: August, 27 2018 05:30
Arrayit receives approval for in-store promotions by a major retail chain
Arrayit Corporation ( OTCPK:ARYC ) has been approved for in-store allergy testing promotions by a major U.S. retailer. Arrayit sales and marketing experts will conduct allergy test promotions in-store, and medical professionals at in-store clinics will collect finger stick blood speci...
Source: SeekingAlpha
Date: August, 13 2018 06:47
Arrayit Corporation Receives Approval for In-Store Promotions by a Major Retail Chain
Sunnyvale, Aug. 13, 2018 (GLOBE NEWSWIRE) -- August 13, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, has been approved for in-store allergy testing promotions by a major United States retailer.  Arrayit sales and ...
Source: GlobeNewswire
Date: August, 13 2018 05:30
Arrayit Corporation Signs Allergy Testing Contracts with a Nationwide Consortium of Medical Clinics
Sunnyvale, July 30, 2018 (GLOBE NEWSWIRE) -- July 30, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, signs allergy testing contracts with a consortium of medical clinics nationwide.  The network comprises 178 medica...
Source: GlobeNewswire
Date: July, 30 2018 05:30
Arrayit Corporation Reports Clinical Instrumentation Sale to the United States Food and Drug Administration
Sunnyvale, July 16, 2018 (GLOBE NEWSWIRE) -- July 16, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces the sale of clinical instrumentation to the United States Food and Drug Administration (FDA). Arrayit uses th...
Source: GlobeNewswire
Date: July, 16 2018 05:30
Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation's Largest Retail Chains
Sunnyvale, July 02, 2018 (GLOBE NEWSWIRE) -- July 2, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that the company has completed an allergy testing pilot program for one of nation’s largest chains of r...
Source: GlobeNewswire
Date: July, 02 2018 05:30
Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network
Sunnyvale, June 18, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network June 18, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that the company ...
Source: GlobeNewswire
Date: June, 18 2018 05:30
Arrayit Corporation Achieves Testing Accuracy Required for Medicare and Medicaid Reimbursement
Sunnyvale, CA , May 30, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that the company has achieved the clinical testing accuracy required for reimbursement under Medicare and Medicaid.  Accuracy testing, superv...
Source: GlobeNewswire
Date: May, 30 2018 08:30
Arrayit Corporation Scores 100% on Proficiency Testing Conducted by the College of American Pathologists
Sunnyvale, CA, May 16, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that the company scored 100% on clinical laboratory proficiency testing conducted by the College of American Pathologists (CAP).  Arrayit rece...
Source: GlobeNewswire
Date: May, 16 2018 08:30
Arrayit Corporation Announces New Clinical Licensure from the Centers for Medicare and Medicaid Services
Sunnyvale, May 09, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces receipt of a new clinical licensure from the Centers for Medicare and Medicaid Services (CMS), which oversees the Clinical Laboratory Improvement Amend...
Source: GlobeNewswire
Date: May, 09 2018 08:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-11-160.0550.0610.0610.055955,081
2018-11-150.0590.0550.060.052751,244,846
2018-11-140.0610.060.0610.0555834,120
2018-11-130.0610.0610.0610.0561161,850
2018-11-120.060.060510.06170.058114,812

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-16618,797955,08164.7900Short
2018-11-15929,2061,244,84674.6443Short
2018-11-14481,475834,12057.7225Short
2018-11-1349,636161,85030.6679Cover
2018-11-1262,500114,81254.4368Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ARYC.


About Arrayit Corp. (OTC: ARYC)

Logo for Arrayit Corp. (OTC: ARYC)

lt p gt Arrayit leads professionals in the microarray industry by developing, manufacturing and marketing life science tools and integrated laboratory platforms for the analysis of genetic variation, biological function, and diagnostics. Arrayit provides it specialized equipment, tools, microarray manufacturing services to more than , research laboratories, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies around the globe. lt /p gt

 

 

 

Current Management

  • Rene A. Schena / CEO
  • Mark Schena / President, Secretary, Treasurer, CTO
  • Todd Martinsky / EVP
  • Philip Ruben / Securities Counsel

Current Share Structure

  • Market Cap: $11,489,302 - 03/09/2018
  • Authorized: 480,000,000 - 04/15/2015
  • Issue and Outstanding: 696,321,311 - 11/20/2015
  • Float: 30,712,404 - 04/15/2015

 


Recent Filings from (OTC: ARYC)

Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: March, 22 2018

 

 


Daily Technical Chart for (OTC: ARYC)

Daily Technical Chart for (OTC: ARYC)


Stay tuned for daily updates and more on (OTC: ARYC)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ARYC)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ARYC is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ARYC and does not buy, sell, or trade any shares of ARYC. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/